This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
Science translational medicine, 9(402)
Citation
Alhadj Ali, Mohammad; Liu, Yuk-Fun; Arif, Sefina; Tatovic, Danijela; Shariff, Hina; Gibson, Vivienne B; Yusuf, Norkhairin; Baptista, Roman; Eichmann, Martin; Petrov, Nedyalko; Heck, Susanne; Yang, Jennie H M; Tree, Timothy I M; Pujol-Autonell, Irma; Yeo, Lorraine; Baumard, Lucas; Stenson, Rachel; Howell, Alex; Clark, Alison; Boult, Zoe; Powrie, Jake; Adams, Laura; Wong, Florence S; Luzio, Stephen; Dunseath, Gareth; Green, Kate; O'Keefe, Alison; Bayly, Graham; Thorogood, Natasha; Andrews, Robert; Leech, Nicola; Joseph, Frank; Nair, Sunil; Seal, Susan; Cheung, HoYee; Beam, Craig; Hills, Robert; Peakman, Mark; Dayan, Colin M. (2017). Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.. Science translational medicine, 9(402). https://doi.org/10.1126/scitranslmed.aaf7779